Therapeutic equivalence? [Design Issues]

posted by bjkim97  – Korea / Seoul, 2011-03-03 13:37 (5095 d 10:35 ago) – Posting: # 6693
Views: 5,703

Thank you for reply MR Dan

But no one expected the authorities of your country permit did not have?
As you know yourself, FDA recommend that patients with Imatinib to look at is.
Not available as well as healthy adults, but not the PK DATA, Issue, did not we.

Yet I did not proceed too many questions to be asked.
We look forward to in kind. ^_^;;

Thank you so much Dan
BJ


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
34 visitors (0 registered, 34 guests [including 5 identified bots]).
Forum time: 00:12 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5